Sponsor Pipeline

Alpha Biopharma (Jiangsu) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07361705 Zorifertinib With Osimertinib for NSCLC With Meningeal Progression Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment Recruiting
NCT07620951 Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China EGFR Mutant Advanced Non-small Cell Lung Cancer Recruiting
Not specified
NCT07143045 A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With… EGFR Mutant Advanced Non-small Cell Lung Cancer Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3)
Get alerts when Alpha Biopharma (Jiangsu) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free